Flaraxin Adenoma of the prostate myoma uterine fibroids Lung Cancer Colorectal cancer prevention breast cancer treatment flaraxin bottles buy store of traditional medicine and sports nutrition. Availability in stock. Fast delivery.
Flaraxin (injectable) - antitumor, antiviral herbal remedies, has interferogennymi properties, stimulates tumor necrosis factor, is a protector to healthy cells during chemotherapy. Has strong antioxidant properties. Detoxifies and reduces the overall toxicity, safe to use. In most cases it is possible to achieve tumor regression and destruction of metastatic damage to other organs.
Prevent relapse. FLARAXIN compatible with various drugs, with the exception of iron-containing. In the combined treatment with chemotherapy and radiotherapy, enhances the effect of the drug on onco-cells and significantly reduces the toxic damage to normal cells.
brain tumor (glioma, ependymoma, oligodendroglioma, etc.);
skin cancer (melanoblastoma, melanoma, basal cell carcinoma et al.);
cancer of female genitalia (uterus, cervix, ovaries);
kidney tumor (adenocarcinoma);
prostate cancer (adenoma);
tumor of the pharynx and larynx;
tumor of the esophagus;
in benign tumors (fibroids, uterine et al.);
neoplastic diseases of the blood and lymphatic system.
FLARAXIN should be used in patients with precancerous proliferative processes, as well as in patients with minimal tumor process, after radical surgery when it is necessary to carry out the restoration of antitumor resistance of the organism and its homeostatic mechanisms;
Treatment may be FLARAXIN basic background and precede polychemotherapy and radiotherapy, besides its possible use in the intervals between treatment cycles but also as a drug for stabilizing the results achieved in the classic anticancer therapy. This is due to its minimal toxicity and selectivity for tumor tissue;
In patients with advanced tumor process FLARAXIN appropriate to apply in the complex polihimioterpii, radiotherapy, using its specific anti-tumor activity and anti-virus, immune-boosting properties;
At impossibility of chemo- and radiotherapy, FLARAXIN used independently.
FLARAXIN ability to stimulate the production of endogenous interferon and tumor necrosis factor;
Normalization of immunological background in cancer patients, normalization of relations immunocompetent cells CD4 / CD8 (helper-suppressor) and an increase in the number of natural killer cells (NK-cells);
Immunobiohimicheskie studies established the ability to communicate with FLARAXIN oncofetal proteins, causing them to mikrodenaturatsionnye damage;
Carcinostatic effect is explained by the influence of FLARAXIN the metabolism of tumor cells, causing their death.